Skip to main content
Figure 3 | BMC Cancer

Figure 3

From: The prognostic values of EGFR expression and KRAS mutation in patients with synchronous or metachronous metastatic colorectal cancer

Figure 3

The Kaplan-Meier survival curve for patients with synchronous mCRC. A. Overall survival stratified by EGFR expression. B. Disease-free survival stratified by EGFR expression. C. Overall survival stratified by KRAS mutation status. D. Disease-free survival stratified by KRAS mutation status. E. Overall survival stratified by wild-type KRAS, codon 12, and codon 13. F. Disease-free survival stratified by wild-type KRAS, codon 12, and codon 13.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us